Breakout Setups
INDV appears in our Breakout Setups screen. This means the stock shows strong technical strength, a constructive consolidation pattern, and enough volatility to support a potential breakout if price moves above resistance.
INDIVIOR PHARMACEUTICALS INC (INDV) Stock Price & Overview
NASDAQ:INDV • US45579U1097
Current stock price
33.415 USD
+1.19 (+3.68%)
Last:
The current stock price of INDV is 33.415 USD. Today INDV is up by 3.68%. In the past month the price increased by 9.66%. In the past year, price increased by 178.81%.
INDV Key Statistics
52-Week Range10.63 - 38
Current INDV stock price positioned within its 52-week range.
1-Month Range27.68 - 33.62
Current INDV stock price positioned within its 1-month range.
- Market Cap
- 4.074B
- P/E
- 13.58
- Fwd P/E
- 10.61
- EPS (TTM)
- 2.46
- Dividend Yield
- N/A
INDV Stock Performance
Today
+3.68%
1 Week
-2.24%
1 Month
+9.66%
3 Months
-2.24%
Longer-term
6 Months +28.25%
1 Year +178.81%
2 Years +83.54%
3 Years N/A
5 Years N/A
10 Years N/A
INDV Stock Chart
INDV Stock Screens
INDV currently appears in the following ChartMill screener lists.
INDV Technical Analysis
ChartMill assigns a technical rating of 8 / 10 to INDV. When comparing the yearly performance of all stocks, INDV is one of the better performing stocks in the market, outperforming 95.32% of all stocks.
Chartmill TA Rating
Chartmill Setup Rating
INDV Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to INDV. INDV has an excellent profitability rating, but there are some minor concerns on its financial health.
Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
INDV Earnings
On February 26, 2026 INDV reported an EPS of 0.82 and a revenue of 358.00M. The company beat EPS expectations (19.28% surprise) and beat revenue expectations (14.84% surprise).
Next Earnings DateApr 30, 2026
Last Earnings DateFeb 26, 2026
PeriodQ4 / 2025
EPS Reported$0.82
Revenue Reported358M
EPS Surprise 19.28%
Revenue Surprise 14.84%
INDV Forecast & Estimates
13 analysts have analysed INDV and the average price target is 47.79 USD. This implies a price increase of 43.03% is expected in the next year compared to the current price of 33.415.
For the next year, analysts expect an EPS growth of 27.98% and a revenue growth -2.63% for INDV
Analysts
Analysts84.62
Price Target47.79 (43.02%)
EPS Next Y27.98%
Revenue Next Year-2.63%
INDV Groups
Sector & Classification
INDV Financial Highlights
Over the last trailing twelve months INDV reported a non-GAAP Earnings per Share(EPS) of 2.46. The EPS increased by 459.09% compared to the year before.
Income Statements
Revenue(TTM)N/A
Net Income(TTM)122.00M
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 10.34% | ||
| ROA | 8.62% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
Chartmill High Growth Momentum
EPS Q2Q%156.25%
Sales Q2Q%20.13%
EPS 1Y (TTM)459.09%
Revenue 1Y (TTM)N/A
INDV Ownership
Ownership
Inst Owners90.94%
Shares121.92M
Float116.75M
Ins Owners3.95%
Short Float %11.47%
Short Ratio5.15
INDV Latest News, Press Relases and Analysis
a day ago - By: Chartmill
INDV Competitors/Peers
The largest stocks on the US markets in the "Pharmaceuticals" sub-industry
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 25.92 | 853.191B | ||
| JNJ | JOHNSON & JOHNSON | 17.83 | 544.731B | ||
| MRK | MERCK & CO. INC. | 22.08 | 278.01B | ||
| PFE | PFIZER INC | 9.15 | 155.349B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 9.33 | 121.259B | ||
| ZTS | ZOETIS INC | 16.59 | 49.697B | ||
| RPRX | ROYALTY PHARMA PLC- CL A | 9.6 | 28.547B | ||
| VTRS | VIATRIS INC | 5.9 | 17.152B | ||
| ELAN | ELANCO ANIMAL HEALTH INC | 21.3 | 11.291B | ||
| AXSM | AXSOME THERAPEUTICS INC | N/A | 9.359B | ||
| BLTE | BELITE BIO INC - ADR | N/A | 6.199B | ||
| TERN | TERNS PHARMACEUTICALS INC | N/A | 6.101B | ||
| CORT | CORCEPT THERAPEUTICS INC | 84.57 | 4.797B |
Related stock screener links
View all stocks in the Pharmaceuticals Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About INDV
Company Profile
Indivior Pharmaceuticals, Inc is a US-based company operating in Pharmaceuticals industry.
Company Info
IPO: 2023-06-12
INDIVIOR PHARMACEUTICALS INC
10710 Midlothian Turnpike, Suite 125, North Chesterfield
SLOUGH VIRGINIA US
Employees: 1030
Phone: 18043791090
INDIVIOR PHARMACEUTICALS INC / INDV FAQ
What does INDV do?
Indivior Pharmaceuticals, Inc is a US-based company operating in Pharmaceuticals industry.
What is the current price of INDV stock?
The current stock price of INDV is 33.415 USD. The price increased by 3.68% in the last trading session.
Does INDIVIOR PHARMACEUTICALS INC pay dividends?
INDV does not pay a dividend.
What is the ChartMill technical and fundamental rating of INDV stock?
INDV has a ChartMill Technical rating of 8 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
On which exchange is INDV stock listed?
INDV stock is listed on the Nasdaq exchange.
How is the valuation of INDIVIOR PHARMACEUTICALS INC (INDV) based on its PE ratio?
The PE ratio for INDIVIOR PHARMACEUTICALS INC (INDV) is 13.58. This is based on the reported non-GAAP earnings per share of 2.46 and the current share price of 33.415 USD.
Can you provide the number of employees for INDIVIOR PHARMACEUTICALS INC?
INDIVIOR PHARMACEUTICALS INC (INDV) currently has 1030 employees.